- With the new cobas EBV and cobas BKV Tests on the cobas 6800/8800 Systems, healthcare professionals can now determine which transplant patients are at risk of further complications caused by ...

PLEASANTON, Calif., May 23, 2019 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) 510(k) clearance for the cobas® TV/MG test for use on the ...

New Breakthrough Device test expands Roche molecular test menu for transplant patients, enabling simultaneous testing of BK virus with Cytomegalovirus and Epstein-Barr virus Basel, 8 September 2020 - ...

The cobas SARS-CoV-2 Qualitative test is one of the first COVID-19 PCR tests performed on an automated, high throughput platform to receive FDA 510(k) clearance. This FDA clearance will ensure that ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received FDA approval for the cobas® HIV-1 viral load test by the United States Food and Drug Administration (FDA) for use on the cobas® ...

The new cobas 6800/8800 systems 2.0 enhances throughput, run flexibility, enables sample prioritisation and is available as an upgrade to existing systems in healthcare settings around the world.

Swiss biotech company Roche announced on December 21, 2015 that the FDA has approved the Cobas® 6800 and 8800 Systems from its Pleasanton, California-based Roche Molecular Diagnostics (RMD) for the ...

The new molecular test broadens Roche’s sexual-health diagnostics portfolio by enabling simultaneous detection of bacterial vaginosis and Candida vaginitis from a single sample. ・Roche (USOTC:RHHBY) ...

Roche announced that the World Health Organization (WHO) has awarded the cobas HPV test prequalification designations for use on the cobas 5800 system and for self-collected samples on the cobas 5800, ...

(RTTNews) - Swiss drug major Roche (RHHBY) Monday said the US Food and Drug Administration, or the FDA, has granted 510(k) clearance for cobas CT/NG for use on the cobas 6800/8800 Systems for the ...